Alkem Laboratories Ltd - 539523 - Fixes Record Date for Interim Dividend
Alkem Laboratories Ltd has informed BSE that the Company has fixed February 18, 2019 as the Record Date for the purpose of Payment of Interim Dividend.The date of payment of lnterim Dividend shall be on and from February 21, 2019. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 8th February, 2019, has adopted the revised "Code of Practices and Procedures for Fair Disclosure" (Revised Code) effective from 1st April, 2019 in compliance with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. The copy of the Revised Code is enclosed herewith. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
We refer to our earlier communication dated 27th December, 2018 regarding closure of trading window (for the purpose of financial results for the quarter ended 31st December, 2018) starting from 30th December, 2018 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2018 are communicated to the Stock Exchanges. The Financial Results of the Company for the quarter and nine months ended 31st December, 2018 having been communicated to the Stock Exchanges, today i.e. 8th February, 2019, the trading window shall open on 11th February, 2019. Alkem Laboratories Ltd - 539523 - Cut-Off Date For Postal Ballot
This is to inform you that pursuant to the provisions of Section 110 and other applicable provisions, if any, of the Companies Act, 2013 read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, the Board of Directors at its meeting held today i.e. 8th February, 2019 have decided to seek approval of the shareholders by way of postal ballot (including voting by electronic means) for the purpose of re-classification of Mr. Nawal Kishore Singh from Promoter Group category to Public category. The Company has fixed 10th May, 2019 as cut-off date for ascertaining the eligibility of shareholders for dispatch of Postal Ballot Notice and voting through electronic means/physical Postal Ballot Form. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Request Received From A Member Of The Promoter Group For Reclassification From The Promoter/Promoter Group Of Alkem Laboratories Limited ('The Company')
In furtherance to our earlier communication dated 22nd November, 2018, this is to inform you that the Board of Directors in their meeting held today, i.e. 8th February, 2019, considered the request received from Mr. Nawal Kishore Singh, part of the Promoter Group of the Company, for re-classification as a public shareholder in accordance with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 ('Listing Regulations'). Kindly take the same on record. Alkem Labs Q3 net profit rises 14% to Rs 205.45 cr
Drug firm Alkem Laboratories on Friday reported a 13.58 per cent rise in its consolidated net profit to Rs 205.45 crore for the quarter ended Decemb Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend
In continuation of our letter dated 1st February, 2019, the Board of Directors of the Company, at its meeting held today, i.e. 8th February, 2019 inter alia, has declared Interim Dividend of Rs. 8/- (Rupees Eight only) per equity share on the face value of Rs. 2/- per share for the financial year 2018-19 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. The date of payment of Interim Dividend shall be on and from 21st February, 2019. Further, as informed vide our letter dated 1st February, 2019 submitted to the Stock Exchanges pursuant to Clause 42 of the Listing Regulations, the record date for the purpose of payment of interim dividend for the financial year 2018-19 would be Monday, 18th February, 2019. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31St December, 2018 And Declaration Of Interim Dividend.
The Board of Directors of the Company, at its meeting held today, i.e. 8th February, 2019 inter alia, has: a. Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2018. A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company is enclosed herewith. b. Declared Interim Dividend of Rs. 8/- (Rupees Eight only) per equity share on the face value of Rs. 2/- per share for the financial year 2018-19. The date of payment of Interim Dividend shall be on and from 21st February, 2019. Further, as informed vide our letter dated 1st February, 2019 submitted to the Stock Exchanges pursuant to Clause 42 of the Listing Regulations, the record date for the purpose of payment of interim dividend for the financial year 2018-19 would be Monday, 18th February, 2019. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. and concluded at 1.30 p.m. Alkem Laboratories Ltd - 539523 - Outcome of Board Meeting
In continuation of our letter dated 1st February, 2019, the Board of Directors of the Company, at its meeting held today, i.e. 8th February, 2019 inter alia, has: a. Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2018 pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'). A copy of the said Financial Results and Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Listing Regulations, is enclosed herewith. b. Declared Interim Dividend of Rs. 8/- (Rupees Eight only) per equity share on the face value of Rs. 2/- per share for the financial year 2018-19 pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. The date of payment of Interim Dividend shall be on and from 21st February, 2019. Further, as informed vide our letter dated 1st February, 2019 submitted to the Stock Exchanges pursuant to Clause 42 of the Listing Regulations, the record date for the purpose of payment of interim dividend for the financial year 2018-19 would be Monday, 18th February, 2019. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. and concluded at 1.30 p.m. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This is to inform you that US FDA had conducted an inspection of the Company's manufacturing facility located at St Louis, USA from 14th January, 2019 to 5th February, 2019 in a phased manner. At the end of inspection, the Company has received Form 483 that contains eight (8) observations. The Company shall submit to US FDA within the stipulated timeline a detailed response with suitable corrective and preventive measures to address the observations. Kindly take note of the same.